Nature Communications (Jul 2022)

Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration

  • Anne Senabouth,
  • Maciej Daniszewski,
  • Grace E. Lidgerwood,
  • Helena H. Liang,
  • Damián Hernández,
  • Mehdi Mirzaei,
  • Stacey N. Keenan,
  • Ran Zhang,
  • Xikun Han,
  • Drew Neavin,
  • Louise Rooney,
  • Maria Isabel G. Lopez Sanchez,
  • Lerna Gulluyan,
  • Joao A. Paulo,
  • Linda Clarke,
  • Lisa S. Kearns,
  • Vikkitharan Gnanasambandapillai,
  • Chia-Ling Chan,
  • Uyen Nguyen,
  • Angela M. Steinmann,
  • Rachael A. McCloy,
  • Nona Farbehi,
  • Vivek K. Gupta,
  • David A. Mackey,
  • Guy Bylsma,
  • Nitin Verma,
  • Stuart MacGregor,
  • Matthew J. Watt,
  • Robyn H. Guymer,
  • Joseph E. Powell,
  • Alex W. Hewitt,
  • Alice Pébay

DOI
https://doi.org/10.1038/s41467-022-31707-4
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Age-related macular degeneration (AMD) is a leading cause of vision loss, and there is no approved treatment for AMD with geographic atrophy. Here, the authors used transcriptomic and proteomic analyses of patient induced pluripotent stem cell-derived retinal pigment epithelium to better understand disease mechanisms.